[1]
2026. Association of Serum Ferritin with Metabolic Syndrome, Insulin Resistance, Dyslipidemia, and Abdominal Obesity: A Systematic Review. World Journal of Current Medical and Pharmaceutical Research. 8, 3 (Nov. 2026), 318–322. DOI:https://doi.org/10.37022/wjcmpr.v8i3.477.